CORC

浏览/检索结果: 共10条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:36/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:38/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:32/0  |  提交时间:2019/12/05
Nomogram prediction of individual prognosis of patients with acute-on-chronic hepatitis B liver failure 期刊论文
DIGESTIVE AND LIVER DISEASE, 2019, 卷号: 51, 期号: 3
作者:  Gao, Fangyuan;  Zhang, Qianqian;  Liu, Yao;  Gong, Guozhong;  Mao, Dewen
收藏  |  浏览/下载:27/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:30/0  |  提交时间:2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/05
Real-world treatment patterns and clinical outcomes of HCV treatment-naive patients in China: an interim analysis from the CCgenos study 期刊论文
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 卷号: 32, 期号: 1
作者:  Rao, Hui-ying;  Li, Hong;  Chen, Hong;  Shang, Jia;  Xie, Qing
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Hepatitis C virus NS5A drives a PTEN-PI3K/Akt feedback loop to support cell survival 期刊论文
LIVER INTERNATIONAL, 2015, 卷号: 35, 期号: 6
作者:  Cheng, Du;  Zhang, Leiliang;  Yang, Guangbo;  Zhao, Lei;  Peng, Feng
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
HCV  NF-B  NS5A  PTEN  ROS  
PREVALENCE OF HCV AND HOST IL28B GENOTYPES IN CHINA 会议论文
作者:  Wei, Lai;  Lopez-Talavera, Juan Carlos;  Rao, Huiying;  Jia, Shang;  Sun, Yongtao
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
PREVALENCE OF HCV AND HOST IL28B GENOTYPES IN CHINA 会议论文
作者:  Wei, Lai;  Lopez-Talavera, Juan Carlos;  Rao, Huiying;  Jia, Shang;  Sun, Yongtao
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace